Brief: Poseida Therapeutics Provides Financial Results For The Fourth Quarter And Full Year 2022
09/03/2023 21:15
March 9 (Reuters) - Poseida Therapeutics Inc PSTX.O :
* POSEIDA THERAPEUTICS PROVIDES UPDATES AND FINANCIAL
RESULTS FOR
THE FOURTH QUARTER AND FULL YEAR 2022
* POSEIDA THERAPEUTICS INC - QTRLY NET LOSS PER SHARE, BASIC
AND
DILUTED $0.39
* POSEIDA THERAPEUTICS - CASH, CASH EQUIVALENTS, SHORT-TERM
INVESTMENTS,MILESTONES & OTHER PAYMENTS WILL BE SUFFICIENT TO
FUND OPERATIONS INTO AT LEAST MID-2024
Source text for Eikon: ID:nPn39l2r8a
Further company coverage: PSTX.O
((Reuters.Briefs@thomsonreuters.com;))